Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Clover Health Investments, Corp. /de (CLOV) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Clover Health Investments, Corp. /de. Table 2 shows the detailed insider transactions. This company's CIK number is 1801170.
Total stock buying since 2021: $12,717,722.
Total stock sales since 2021: $2,025,462.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 473,480 | $1,067,763 | 586,371 | $2,025,462 | 1,670,965 | $0 |
| 2024 | 709,410 | $1,135,082 | 0 | $0 | 0 | $0 |
| 2023 | 11,000 | $14,300 | 0 | $0 | 1,569,594 | $0 |
| 2022 | 180,000 | $500,580 | 0 | $0 | 3,515,098 | $0 |
| 2021 | 1,739,130 | $9,999,997 | 0 | $0 | 43,445,980 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 473,480 | $1,067,763 | 6,823 | $19,718 | 0 | $0 |
| 2025-07 | 0 | $0 | 231,598 | $749,757 | 0 | $0 |
| 2025-06 | 0 | $0 | 20,450 | $58,487 | 0 | $0 |
| 2025-03 | 0 | $0 | 327,500 | $1,197,500 | 0 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 1,670,965 | $0 |
| 2024-08 | 531,700 | $999,596 | 0 | $0 | 0 | $0 |
| 2024-05 | 27,085 | $25,530 | 0 | $0 | 0 | $0 |
| 2024-03 | 150,625 | $109,956 | 0 | $0 | 0 | $0 |
| 2023-09 | 11,000 | $14,300 | 0 | $0 | 0 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 1,569,594 | $0 |
| 2022-09 | 0 | $0 | 0 | $0 | 118,200 | $0 |
| 2022-03 | 180,000 | $500,580 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 0 | $0 | 3,396,898 | $0 |
| 2021-11 | 1,739,130 | $9,999,997 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 0 | $0 | 2,245,980 | $0 |
| 2021-01 | 0 | $0 | 0 | $0 | 41,200,000 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | Loengard Anna U (Director) | Buy | 26,500 | 2.60 | 68,767 |
| 2025-08-08 | Garipalli Vivek | Buy | 31,980 | 2.17 | 69,396 |
| 2025-08-07 | Garipalli Vivek | Buy | 415,000 | 2.24 | 929,600 |
| 2025-08-04 | Reynoso Jamie L. (CEO, Medicare Advantage) | Sale | 6,823 | 2.89 | 19,718 |
| 2025-07-23 | Wai Conrad (CEO, Counterpart Health) | Sale | 91,197 | 3.32 | 302,774 |
| 2025-07-22 | Wai Conrad (CEO, Counterpart Health) | Sale | 118,600 | 3.29 | 390,194 |
| 2025-07-07 | Reynoso Jamie L. (CEO, Medicare Advantage) | Sale | 2,012 | 2.85 | 5,734 |
| 2025-07-03 | Reynoso Jamie L. (CEO, Medicare Advantage) | Sale | 19,789 | 2.58 | 51,055 |
| 2025-06-17 | Reynoso Jamie L. (CEO, Medicare Advantage) | Sale | 20,450 | 2.86 | 58,487 |
| 2025-03-07 | Edwards Carladenise Armbrister (Director) | Sale | 200,000 | 3.61 | 722,000 |
| 2025-03-06 | Soares Karen (General Counsel & Secretary) | Sale | 52,500 | 3.80 | 199,500 |
| 2025-03-06 | Priest Brady Patrick (CEO of Home Care) | Sale | 75,000 | 3.68 | 276,000 |
| 2025-01-07 | Garipalli Vivek | Option Ex | 1,670,965 | .00 | 0 |
| 2024-08-09 | Garipalli Vivek | Buy | 531,700 | 1.88 | 999,596 |
| 2024-05-17 | Loengard Anna U (Director) | Buy | 10,000 | .93 | 9,300 |
| 2024-05-16 | Loengard Anna U (Director) | Buy | 17,085 | .95 | 16,230 |
| 2024-03-14 | Loengard Anna U (Director) | Buy | 150,625 | .73 | 109,956 |
| 2023-09-06 | Loengard Anna U | Buy | 11,000 | 1.30 | 14,300 |
| 2023-01-07 | Garipalli Vivek (Executive Chairperson) | Option Ex | 1,569,594 | .00 | 0 |
| 2022-09-22 | Kouzoukas Demetrios L. | Option Ex | 25,608 | .00 | 0 |
| 2022-09-22 | Robinson William G Jr | Option Ex | 27,100 | .00 | 0 |
| 2022-09-22 | Clinton Chelsea | Option Ex | 38,392 | .00 | 0 |
| 2022-09-22 | Shapiro Lee | Option Ex | 27,100 | .00 | 0 |
| 2022-03-11 | Shapiro Lee | Buy | 80,000 | 3.10 | 248,080 |
| 2022-03-03 | Clinton Chelsea | Buy | 100,000 | 2.52 | 252,500 |
| 2022-01-07 | Garipalli Vivek (Chief Executive Officer) | Option Ex | 3,342,698 | .00 | 0 |
| 2022-01-07 | Robinson William G Jr | Option Ex | 27,100 | .00 | 0 |
| 2022-01-07 | Shapiro Lee | Option Ex | 27,100 | .00 | 0 |
| 2021-11-22 | Sch Sponsor Iii Llc (Other) | Buy | 1,739,130 | 5.75 | 9,999,997 |
| 2021-08-16 | Sch Sponsor Iii Llc (Other) | Option Ex | 2,245,980 | .00 | 0 |
| 2021-01-07 | Chachacha Spac C, Llc (10% Owner) | Option Ex | 20,500,000 | .00 | 0 |
| 2021-01-07 | Ryans James (Other) | Option Ex | 100,000 | .00 | 0 |
| 2021-01-07 | Osborne Ian (Other) | Option Ex | 20,500,000 | .00 | 0 |
| 2021-01-07 | Reses Jacqueline D (Other) | Option Ex | 100,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of CLOV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Clover Health Investments, Corp. /de (symbol CLOV, CIK number 1801170) see the Securities and Exchange Commission (SEC) website.